Bryson, S.E., Rogers, S.J., & Fombonne, E. (2003). Autism spectrum disorders: Early detection, intervention, education, and psychopharmacological management. Canadian Journal of Psychiatry, 48(8), 506-516.
Doyle, C.A., & McDougle, C.J. (2012). Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan. Dialogues in Clinical Neuroscience, 14(3), 263-279.
Elbe, D., & Lalani, Z. (2012). Review of the pharmacotherapy of irritability of autism. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 21(2),130-146.
Francis, K. (2005). Autism interventions: A critical update. Developmental Medicine and Child Neurology, 47(7), 493-499. doi: 10.1111/j.1469-8749.2005.tb01178.x.
LeClerc, S., & Easley, D. (2015). Pharmacological therapies for autism spectrum disorder: A review. Pharmacology and Therapeutics, 40(6), 389-397.
Leskovec, T.J., Rowles, B.M., & Findling, R.L. (2008). Pharmacological treatment options for autism spectrum disorders in children and adolescents. Harvard Review of Psychiatry, 16, 97-112.
National Autism Center (2015). Findings and conclusions: National standards project, phase 2. Randolph, MA: National Autism Center. Retrieved 26 September 2016 from http://www.nationalautismcenter.org/national-standards-project/results-reports/.
Prior, M., & Roberts, J. (2012). Early intervention for children with autism spectrum disorders: Guidelines for good practice. Canberra: Australian Government Department of Social Services. Retrieved 23 June 2016 from https://www.dss.gov.au/our-responsibilities/disability-and-carers/program-services/for-people-with-disability/early-intervention-for-children-with-autism-spectrum-disorders-guidelines-for-good-practice-2012.
Prior, M., Roberts, J.M., Rodger, S., Williams, K., & Sutherland, R. (2011). A review of the research to identify the most effective models of practice in early intervention for children with autism spectrum disorders. Canberra: Australian Government Department of Families, Housing, Community Services and Indigenous Affairs. Retrieved 26 September 2016 from https://www.dss.gov.au/sites/default/files/documents/10_2014/review_of_the_research_report_2011_0.pdf.
Ray, W.A., Chung, C.P., Murray, K.T., Hall, K., & Stein, C.M. (2009). Atypical antipsychotic drugs and the risk of sudden cardiac death. New England Journal of Medicine, 360(3), 225-235. doi: 10.1056/NEJMoa0806994.
Sikich, L. (2001). Psychopharmacologic treatment studies in autism. In E. Schopler, N. Yirmiya, C. Shulman & L.M. Marcus (Eds), The research basis for autism interventions (pp. 199-218). New York: Plenum.
Weitlauf, A.S., McPheeters, M.L., Peters, B., Sathe, N., Travis, R., Aiello, R., Williamson, E., Veenstra-VanderWeele, J., Krishnaswami, S., Jerome, R., & Warren, Z. (2014). Therapies for children with autism spectrum disorder: Behavioral interventions update. Comparative Effectiveness Review no. 137 [AHRQ Publication No. 14-EHC036-EF]. Rockville, MD: Agency for Healthcare Research and Quality. Retrieved 25 July 2016 from http://www.ncbi.nlm.nih.gov/books/NBK241444/.
Wong, C., Odom, S.L., Hume, K., Cox, A.W., Fettig, A., Kucharczyk, S., Brock, M.E., Plavnick, J.B., Fleury, V.P., & Schultz, T.R. (2014). Evidence-based practices for children, youth, and young adults with autism spectrum disorder. Chapel Hill, NC: University of North Carolina, Frank Porter Graham Child Development Institute, Autism Evidence-Based Practice Review Group. Retrieved 25 July 2016 from http://fpg.unc.edu/sites/fpg.unc.edu/files/resources/reports-and-policy-briefs/2014-EBP-Report.pdf.